Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Waters (WAT) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDiagnostics & ResearchWAT

Closing price · Nov 19, 2026 $459.33 -1.5% on the day · +22.1% over 12 months 52-week range $283.32 – $480.07
Get WAT alerts
Open-market purchases2 insiders$451K · last 12 months
Insiders selling1last 12 months
Reported sales$1.4M0 of 1 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($451K), but sales were much larger ($1.4M) over the same 12 months.

Past insider buys here: 2 of 2 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale Christopher A. Kuebler, Director sold 3,626 shares at $397.94 ($1.4M).

Trade date
Aug 6, 2026
Disclosed to the SEC
Aug 7, 2026
Type
Sale (code S)

Read the original SEC filing ↗All WAT insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

WAT insider transactions (Form 4)

Open-market purchases and sales. 48 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 7SEC Christopher A. KueblerDirector Sell 3,62617,808 held (−17%) $397.94 $1.4M +15.4% —
Mar 18SEC Wei JiangDirectorFirst buy Buy 5003,441 held (+17%) $289.46 $145K +58.7% —
Mar 10SEC Richard H. FearonDirectorPast buys 0/2 beat S&P Buy 1,0003,302 held (+43%) $306.34 $306K +49.9% 55
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for WAT's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with WAT in the Research Lab

Pre-set to WAT's latest insider buy of $10K or more (Mar 18, 2026: Richard H. Fearon, Wei Jiang, $451K). Tap to change anything.

All tools →

Share price and insider trades

WAT closeInsider buyInsider sale
200300400500DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-09EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04Bought $144,730 on 2026-03-16 · Wei JiangBought $306,340 on 2026-03-06 · Richard H. FearonSold $1,442,930 on 2026-08-06 · Christopher A. Kuebler
Bought, 12 months$451K
Sold, 12 months$1.4M
Insiders buying2
Insiders selling1

Waters insider trading at a glance (Nov 20, 2026): in the past 12 months, 2 insiders bought $451K and 1 sold $1.4M of WAT stock on the open market; P/E 189.8 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

WAT insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $451K bought (2 trades)$451KQ1 2026Q2 2026Q3 2026: $1.4M sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$1.4M1
Q2 2026—0—0
Q1 2026$451K2—0

Valuation, profit and volume

P/E (trailing)189.8Sector median 25.0
Market value$89.13BDiagnostics & Research
Profit margin1.8%Revenue growth +120.9%
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit+$238KOn all tracked purchases +52.7%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 2 Waters Corporation insiders reported open-market purchases totaling $451K, while 1 insider reported sales totaling $1.4M. Among insiders with enough purchase history to measure, Richard H. Fearon (Director) has the highest Insider Score at 55. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

WAT earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 4, 2026 +1.6% None +6.7%S&P +1.6% +2.3%
May 5, 2026 -7.9% None +15.8%S&P +2.2% +4.5%
Feb 9, 2026 -4.8% None -14.2%S&P +0.2% -13.4%
Nov 4, 2025 +3.3% None +7.6%S&P -0.8% +6.1%
Aug 4, 2025 -2.2% None -3.1%S&P +1.0% +6.6%
May 6, 2025 +8.5% None -0.8%S&P -0.4% +1.7%
Feb 12, 2025 -2.2% None -6.5%S&P +0.7% -0.5%
Nov 1, 2024 -8.7% None +19.9%S&P +0.2% +1.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

WAT short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 63% of volume sold short2026-08-27: 59% of volume sold short2026-08-28: 56% of volume sold short2026-08-31: 74% of volume sold short2026-09-01: 66% of volume sold short2026-09-02: 59% of volume sold short2026-09-03: 71% of volume sold short2026-09-04: 60% of volume sold short2026-09-08: 74% of volume sold short2026-09-09: 80% of volume sold short2026-09-10: 74% of volume sold short2026-09-11: 58% of volume sold short2026-09-14: 46% of volume sold short2026-09-15: 64% of volume sold short2026-09-16: 61% of volume sold short2026-09-17: 75% of volume sold short2026-09-18: 74% of volume sold short2026-09-21: 44% of volume sold short2026-09-22: 48% of volume sold short2026-09-23: 45% of volume sold short2026-09-24: 46% of volume sold short2026-09-25: 63% of volume sold short2026-09-28: 63% of volume sold short2026-09-29: 66% of volume sold short2026-09-30: 69% of volume sold short2026-10-01: 68% of volume sold short2026-10-02: 67% of volume sold short2026-10-05: 39% of volume sold short2026-10-06: 66% of volume sold short2026-10-07: 81% of volume sold short2026-10-08: 56% of volume sold short2026-10-09: 41% of volume sold short2026-10-12: 34% of volume sold short2026-10-13: 41% of volume sold short2026-10-14: 59% of volume sold short2026-10-15: 62% of volume sold short2026-10-16: 52% of volume sold short2026-10-19: 52% of volume sold short2026-10-20: 70% of volume sold short2026-10-21: 66% of volume sold short2026-10-22: 71% of volume sold short2026-10-23: 56% of volume sold short2026-10-26: 61% of volume sold short2026-10-27: 77% of volume sold short2026-10-28: 60% of volume sold short2026-10-29: 42% of volume sold short2026-10-30: 30% of volume sold short2026-11-02: 24% of volume sold short2026-11-03: 46% of volume sold short2026-11-04: 68% of volume sold short2026-11-05: 53% of volume sold short2026-11-06: 41% of volume sold short2026-11-09: 57% of volume sold short2026-11-10: 63% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 50% of volume sold short2026-11-13: 56% of volume sold short2026-11-16: 53% of volume sold short2026-11-17: 52% of volume sold short2026-11-18: 73% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 73%20-day average: 51%Prior 2 months: 58%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded WAT

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Sold $1,001 - $15,000 May 3, 2024Aug 5, 2026 +43.0%

What happened after WAT insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Mar 18, 2026Wei JiangDirector$145K +2.5%+2.9% vs S&P+11.1%+3.4% vs S&P+22.2%+8.4% vs S&P
Mar 10, 2026Richard H. FearonDirector$306K -0.9%+0.1% vs S&P+6.0%+5.3% vs S&P+21.3%+11.8% vs S&P

Insiders at Waters Corporation

InsiderBoughtSoldLast filingPast buys beat S&PScore
Christopher A. KueblerDirector — $1.4M Aug 7, 2026 — —
Richard H. FearonDirector $306K — Mar 10, 2026 0 of 2 55
Wei JiangDirector $145K — Oct 2, 2026 — —
Tong (nmn) WuSvp Waters Analytical Sciences — — Nov 16, 2026 — —
Heather KnightDirector — — Oct 2, 2026 — —
Robert L. Carpio IIISvp Waters Analytical Sciences — — Jun 25, 2026 — —
Amol ChaubalCFO — — May 14, 2026 — —
Jianqing BennettSvp Waters Adv. Diagnostics — — Apr 7, 2026 — —
Udit BatraCEO, President — — Mar 3, 2026 — —
Flemming OrnskovDirector — — Feb 27, 2026 — —
Linda BaddourDirector — — Feb 27, 2026 — —
Daniel J. BrennanDirector — — Feb 27, 2026 — —
Claire FraserDirector — — Feb 27, 2026 — —
Pearl S. HuangDirector — — Feb 27, 2026 — —
Mark VergnanoDirector — — Feb 27, 2026 — —

Board links: companies that share insiders with WAT

Directors and executives who filed Form 4s for WAT and another company in the last 12 months.

See the map →
  • CRHCRH Richard H. Fearon Director here · Director at CRH · latest filing Nov 10, 2026
  • JCIJohnson Controls Mark Vergnano Director here · Director at JCI · latest filing Mar 6, 2026
  • SOLVSolventum Heather Knight Director here · Chief Commercial Officer at SOLV · latest filing Nov 19, 2026
  • VRTXVertex Pharmaceuticals Daniel J. Brennan Director here · Director at VRTX · latest filing Oct 22, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

WAT stock: common questions

Are Waters Corporation insiders buying WAT stock?

In the past 12 months, 2 insiders reported open-market purchases of WAT worth $451K. The latest was Director Wei Jiang bought $145K of WAT at $289.46 — first open-market purchase in our records.

Are Waters Corporation insiders selling WAT stock?

1 insider reported sales worth $1.4M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is WAT's P/E ratio?

WAT trades at about 189.8 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is WAT's 52-week range?

Over the past year WAT has traded between $283.32 and $480.07. It last closed at $459.33 on Nov 19, 2026.